Cargando…
Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later
Autores principales: | Cornet, Alain, Andersen, Jeanette, Tani, Chiara, Mosca, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884871/ https://www.ncbi.nlm.nih.gov/pubmed/36697031 http://dx.doi.org/10.1136/lupus-2023-000895 |
Ejemplares similares
-
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
por: Cornet, Alain, et al.
Publicado: (2021) -
Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Epinephrine for Anaphylaxis: Underutilized and Unavailable
por: Dudley, Larissa S., et al.
Publicado: (2015) -
Hydroxychloroquine in SLE: old drug, new perspectives
por: Dörner, Thomas
Publicado: (2010) -
Living with systemic lupus erythematosus in 2020: a European patient survey
por: Cornet, Alain, et al.
Publicado: (2021)